Haris Imran Hiew

from zero to one amzn.to/1u6xqLU

Man to man

Watan noodles mix chicken, eggs,vegetable, Asians foods 😋

🧠 The most popular AI tools of the last month. Which do you use the most? (1/2)

@NotebookLM @NotebookLM should deeply integrate with @gmail pull key emails straight into quizzes & flashcards for faster learning! 📖🙏 #NotebookLM #GoogleForEducation #EdTech

What other Quiz question formats or Flashcard functionality should we build next?

GPT-5.5 on ARC-AGI (Verified) ARC-AGI-2: - Max: 85.0%, $1.87 - High: 83.3%, $1.45 - Med: 70.4%, $0.86 - Low: 33%, $0.35 GPT-5.5 is now state of the art on ARC-AGI-2

Elon says Grok 5 will be AGI, says Grok 4.4 will be 1T to release in early May and Grok 4.5 will be 1.5T and out late May. Grok 4.3 - 0.5T out now in beta Grok 4.4 - 1T out early May Grok 4.5 - 1.5T out late May Grok 5 - AGI Image made by Grok from the thread.

Neverrrrrrr.

@AIatMeta @facebook @alexandr_wang @Meta This would be especially useful in functional cities like Kota Kinabalu for real-time news without switching apps. @alexandr_wang @AIatMeta any plans for deeper FB integration in Muse Spark roadmap? 😃

@AIatMeta Integrate Meta AI apps homepage directly into @facebook: search latest news/feeds dynamically from AI interface. Seamless! @alexandr_wang @AIatMeta @Meta #MetaAI #MuseSpark #AISocial

To build personal superintelligence, our model’s capabilities should scale predictably and efficiently. Below, we share how we study and track Muse Spark’s scaling properties along three axes: pretraining, reinforcement learning, and test-time reasoning. 🧵👇 Let’s start with pretraining. Over the last 9 months, we rebuilt our pretraining stack with improvements to model architecture, optimization, and data curation, enabling us to increase the capability we can extract from every unit of compute. To rigorously evaluate our new recipe, we fit a scaling law to a series of small models and compare the training FLOPs required to hit a specific level of performance. The results: we can reach the same capabilities with over an order of magnitude less compute than our previous model, Llama 4 Maverick, making Muse Spark significantly more efficient than the leading base models available for comparison.

Which Generation Are you?

🤯NEW Google just quietly unleashed AI Edge On-device AI platform that runs powerful Gemma models completely offline. No cloud. No tracking. Full privacy. The Gallery app already lets you run chat, image analysis, agents, and more straight on your phone (and Mac). This is what we’ve been waiting for 👇🏻 github.com/google-ai-edge…

Factors for maintaining diesel subsidies in Sabah and Sarawak (1/2) #BernamaNews #BernamaInfographics #diesel #Sabah #Sarawak

German medical researchers have engineered a novel, injectable hydrogel designed to stimulate the biological regeneration of articular cartilage. This non-surgical approach aims to directly repair joint damage and restore natural cushioning without relying on invasive and costly joint replacement procedures. Orthopedic experts note that osteoarthritis and cartilage degradation affect hundreds of millions globally, often leading to debilitating pain and limited mobility. By utilizing a bioactive matrix that encourages the body's own stem cells to multiply and differentiate into healthy tissue, this gel could drastically shift treatment paradigms away from artificial implants. The underlying technology relies on a specialized polymer network that seamlessly mimics the natural extracellular environment of human joints. Once introduced to the affected area, it acts as a supportive structural scaffold, safely dissolving over time as fresh, healthy cartilage takes its place. Early clinical observations report a significant reduction in chronic joint inflammation and a much faster return to pain-free movement for affected participants. Unlike traditional surgical interventions, which frequently require months of strenuous physical therapy, this minimally invasive procedure could allow for an incredibly rapid recovery window. While currently advancing through rigorous regulatory testing phases, the successful commercialization of this regenerative therapy could save global healthcare systems billions in surgical and rehabilitation costs. It offers a highly promising future where debilitating joint conditions are managed with a simple outpatient visit, permanently restoring active lifestyles for aging populations and athletes alike. If this non-surgical treatment becomes widely available, how would the ability to naturally regrow joint cartilage change your approach to staying active?

Educate yourself.